Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.

Thomas DecaensCarlo BaroneEric AssenatMartin WermkeAngelica FasoloPhilippe MerleJean-Frédéric BlancVéronique GrandoAngelo IacobellisErica VillaJoerg TrojanJosef StraubRolf BrunsKarin BerghoffJuergen ScheeleEric RaymondSandrine Faivre

Published in: British journal of cancer (2021)

ClinicalTrials.gov: NCT02115373.

Keyphrases

phase iii
study protocol
cell proliferation
phase ii
clinical trial
tyrosine kinase
transcription factor
randomized controlled trial
open label
double blind